Endo International Plc (ENDP)

Trade ENDP now with
11/8/2018 7:03:41 AM Endo Intl. Q3 Net Loss Widens To $173.2 Mln Or $0.77/shr From $96.7 Mln Or $0.43/shr Last Year
11/7/2018 7:31:44 AM Endo Announces Positive Results From Phase 3 Studies Of Collagenase Clostridium Histolyticum In Patients With Cellulite
10/11/2018 7:34:20 AM Endo Presents Data On Perception And Measurement Of Cellulite Severity At ASDS Annual Meeting
9/28/2018 8:31:17 AM Endo Pharma Issues Voluntary Nationwide Recall For Two Lots Of Robaxin 750mg Tablets 100 Count Bottle Packs
9/24/2018 6:01:59 AM Endo Int'l Agrees To Additional Stay Of Litigation Against FDA Until Dec 31
8/15/2018 6:03:41 AM Endo Int'l Lifts Temporary Stay Of Litigation Against FDA
8/15/2018 6:02:36 AM Endo Lifts Temporary Stay Of FDA Litigation Following Launch Of Bulk-Compounded Vasopressin Product
8/8/2018 7:08:03 AM Nevakar And Endo Enter Licensing Agreement For Multiple 505(b)(2) Injectable Products
8/8/2018 7:02:20 AM Endo Q2 Loss Per Share From Cont Opns $0.23; Adj EPS From Cont Opns $0.76
8/2/2018 7:32:23 AM Endo Names Laure Park As SVP, Investor Relations And Corporate Affairs